These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18572139)

  • 21. [Chemoembolization of hepatocellular carcinoma with drug eluting beads].
    Kivelä K; Seppänen J; Keski-Nisula L
    Duodecim; 2009; 125(21):2387-93. PubMed ID: 19999664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-loaded microspheres for the treatment of liver cancer: review of current results.
    Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T
    Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of Hepatocellular Carcinoma with Drug-eluting Beads Chemoembolization and Liver Transplantation].
    Yoon HH; Jung YK; Chung DH; Choi SJ; Kim JH; Kim KK
    Korean J Gastroenterol; 2012 Nov; 60(5):335-8. PubMed ID: 23311003
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemoembolization for primary and metastatic liver cancer.
    Liapi E; Geschwind JF
    Cancer J; 2010; 16(2):156-62. PubMed ID: 20404613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.
    Aliberti C; Tilli M; Benea G; Fiorentini G
    Anticancer Res; 2006; 26(5B):3793-5. PubMed ID: 17094403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization.
    Prajapati HJ; Rafi S; El-Rayes BF; Kauh JS; Kooby DA; Kim HS
    J Vasc Interv Radiol; 2012 Oct; 23(10):1286-93.e1. PubMed ID: 22999748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoembolization of hepatocellular carcinoma with drug eluting beads.
    Del Poggio P; Maddeo A; Zabbialini G; Pitì A
    J Hepatol; 2007 Jul; 47(1):157-8; author reply 159. PubMed ID: 17509721
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinoma.
    Vadot L; Boulin M; Guiu B; Aho LS; Vourc'h M; Musat A; Hillon P; Lepage C; Guignard MH; Fagnoni P
    J Clin Pharm Ther; 2015 Feb; 40(1):83-90. PubMed ID: 25413186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous complications following transcatheter arterial chemoembolization.
    Cho E; Kim HS; Park YM; Lee JY; Kim HO
    Int J Dermatol; 2013 Nov; 52(11):1449-50. PubMed ID: 22320396
    [No Abstract]   [Full Text] [Related]  

  • 30. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective.
    Takayasu K
    Oncology; 2013; 84 Suppl 1():28-33. PubMed ID: 23428855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review.
    Idée JM; Guiu B
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):530-49. PubMed ID: 23921081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supraumbilical cutaneous lesions after transcatheter arterial chemoembolization for hepatocellular carcinoma.
    del Alcázar Viladomiu E; López Pestaña A; Tuneu Valls A; Prieto Argarate I; Ruiz Tapiador JI
    J Am Acad Dermatol; 2014 Aug; 71(2):e49-50. PubMed ID: 25037812
    [No Abstract]   [Full Text] [Related]  

  • 33. Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations.
    Lencioni R; Aliberti C; de Baere T; Garcia-Monaco R; Narayanan G; O'Grady E; Rilling WS; Walker D; Martin RC
    J Vasc Interv Radiol; 2014 Mar; 25(3):365-9. PubMed ID: 24581461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma.
    van Malenstein H; Maleux G; Vandecaveye V; Heye S; Laleman W; van Pelt J; Vaninbroukx J; Nevens F; Verslype C
    Onkologie; 2011; 34(7):368-76. PubMed ID: 21734423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Imai N; Ikeda K; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Jpn J Clin Oncol; 2012 Mar; 42(3):175-82. PubMed ID: 22210921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof.
    Liu DM; Thakor AS; Baerlocher M; Alshammari MT; Lim H; Kos S; Kennedy AS; Wasan H
    Future Oncol; 2015; 11(9):1421-8. PubMed ID: 25602287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.
    Poggi G; Quaretti P; Minoia C; Bernardo G; Bonora MR; Gaggeri R; Ronchi A; Saluzzo CM; Azzaretti A; Rodolico G; Montagna M; Amatu A; Teragni C; Palumbo I; Traverso E; Tonini S; Villani L; Scelsi M; Baiardi P; Felisi MG; Sottotetti F; Tagliaferri B; Riccardi A
    Anticancer Res; 2008; 28(6B):3835-42. PubMed ID: 19192637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and feasibility of same-day discharge of patients with hepatocellular carcinoma treated with transarterial chemoembolization with drug-eluting beads in a liver transplantation program.
    Nasser F; Cavalcante RN; Galastri FL; de Rezende MB; Felga GG; Travassos FB; De Fina B; Affonso BB
    J Vasc Interv Radiol; 2014 Jul; 25(7):1012-7. PubMed ID: 24704346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC.
    Koizumi Y; Hirooka M; Uehara T; Kisaka Y; Uesugi K; Kumagi T; Abe M; Matsuura B; Hiasa Y; Onji M
    Hepatogastroenterology; 2011; 58(106):512-5. PubMed ID: 21661422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter arterial chemoembolization of hepatocellular carcinoma: a Japanese experience.
    Higashihara H; Okazaki M
    Hepatogastroenterology; 2002; 49(43):72-8. PubMed ID: 11941988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.